Imidazoquinoxalines and pyrroloquinoxalines

Details Imidazoquinoxalines and pyrroloquinoxalines Imidazoquinoxalines and pyrroloquinoxalines

1980-02-04

1982-06-08

Coughlan, Jr., Paul M.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

4242484, 424258, 544101, 544344, 544346, 546 84, 546 94, C07D24142, C07D24144, C07D48704

Patent

active

043339344

ABSTRACT:
Novel compounds of the formula ##STR1## wherein A is selected from the group consisting of nitrogen and .dbd.CH--, G is selected from the group consisting of ##STR2## Z is selected from the group consisting of hydrogen and alkyl of 1 to 5 carbon atoms or taken with Y forms a carbon-nitrogen or carbon-carbon bond, Z' is selected from the group consisting of hydrogen and halogen, Y is hydrogen, or taken with Z is a carbon-nitrogen or carbon-carbon bond or taken with X is .dbd.O and X is hydrogen or taken with Y is .dbd.O, R is selected from the group consisting of hydroxymethyl, formyl, tetrazol-5-yl, N-(tetrazol-5-yl) carbamoyl, aminomethyl and carbamoyl, R.sub.1 is selected from the group consisting of hydrogen, halogen and alkoxy of 1 to 5 carbon atoms and its non-toxic, pharmaceutically acceptable acid addition salts having antiallergic activity and their preparation.

REFERENCES:
patent: 3706768 (1972-12-01), Bays
patent: 4075343 (1978-02-01), Kadin et al.
patent: 4145419 (1979-03-01), Rowlands et al.
patent: 4151280 (1979-04-01), Rowlands et al.
patent: 4207318 (1980-06-01), Rowlands et al.
patent: 4229452 (1980-10-01), Warner et al.

Affiliated with

Also associated with

Rating

Imidazoquinoxalines and pyrroloquinoxalines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Imidazoquinoxalines and pyrroloquinoxalines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazoquinoxalines and pyrroloquinoxalines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-552787